OTCMKTS:EQUR E-Qure (EQUR) Stock Price, News & Analysis $0.0002 0.00 (0.00%) As of 10/5/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About E-Qure Stock (OTCMKTS:EQUR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get E-Qure alerts:Sign Up Key Stats Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.00▼$0.05VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewE-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.Read More… Receive EQUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for E-Qure and its competitors with MarketBeat's FREE daily newsletter. Email Address EQUR Stock News HeadlinesNBC files FCC 'equal time' notice after Kamala Harris appears on 'SNL'November 12, 2024 | usatoday.comLilly Ledbetter, equal pay and women's rights activist, dies at 86November 3, 2024 | nbcnews.comTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 4, 2025 | Porter & Company (Ad)UCLA Must Ensure Equal Campus Access to Jewish Students, Judge RulesAugust 17, 2024 | wsj.comJudge tells UCLA it must protect Jewish students' equal access on campusAugust 1, 2024 | usatoday.comLabour’s equal pay plan for ethnic minorities is all stakeholder, and no substanceFebruary 9, 2024 | ft.comIs equal pay actually possible?December 8, 2023 | bbc.comEqual Is Not FairDecember 5, 2023 | nasdaq.comSee More Headlines EQUR Stock Analysis - Frequently Asked Questions How have EQUR shares performed this year? E-Qure's stock was trading at $0.0002 on January 1st, 2025. Since then, EQUR shares have increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2025 here. How were E-Qure's earnings last quarter? E-Qure Corp. (OTCMKTS:EQUR) posted its quarterly earnings data on Thursday, September, 17th. The company reported ($0.01) earnings per share (EPS) for the quarter. How do I buy shares of E-Qure? Shares of EQUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of E-Qure own? Based on aggregate information from My MarketBeat watchlists, some other companies that E-Qure investors own include HEXO (HEXO), Bertrandt Aktiengesellschaft (BDT), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY), Aeolus Pharmaceuticals (AOLS) and Advanced Micro Devices (AMD). Company Calendar Last Earnings9/17/2020Today5/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous durable goods Sub-IndustryWholesale Current SymbolOTCMKTS:EQUR CIK1563536 Webwww.e-qure.com Phone(972) 916-7333Fax972-8916-7331Employees1Year Founded2014Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:EQUR) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding E-Qure Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share E-Qure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.